Back
Greystone Housing Impact Investors LP Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
56
GHI
Greystone Housing Impact Investors LP
Last Price:
$13.05
Seasonality Move:
-1.72%
Sell
48
ASND
Ascendis Pharma AS
Last Price:
$166.17
Seasonality Move:
-9.72%
Buy
56
Greystone Housing Impact Investors LP (GHI)
is a Buy
Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?
-
The current Greystone Housing Impact Investors LP [GHI] share price is $13.15. The Score for GHI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
GHI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GHI Stock Price Chart
What is Greystone Housing Impact Investors LP's stock price today?
-
The Greystone Housing Impact Investors LP share price today is $13.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GHI is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $164.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
GHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 61.28 | Buy |
Chaikin Money Flow: | 2485 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.39 - 12.93) | Buy |
Bollinger Bands (100): | (11.14 - 12.7) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.96 | Buy |
Relative Strength Index (14 RSI): | 63.68 | Buy |
Chaikin Money Flow: | -280747 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.08 - 160.62) | Buy |
Bollinger Bands (100): | (124.26 - 145.68) | Buy |
GHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.83 | Buy |
20-day SMA: | 12.63 | Buy |
50-day SMA: | 12.2 | Buy |
200-day SMA: | 13.09 | Buy |
8-day EMA: | 12.84 | Buy |
20-day EMA: | 12.66 | Buy |
50-day EMA: | 12.35 | Buy |
200-day EMA: | 13.06 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 154.01 | Buy |
20-day SMA: | 153.39 | Buy |
50-day SMA: | 139.38 | Buy |
200-day SMA: | 134.63 | Buy |
8-day EMA: | 157.06 | Buy |
20-day EMA: | 151.09 | Buy |
50-day EMA: | 143.18 | Buy |
200-day EMA: | 134.95 | Buy |
Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.03 per share, an increase this year of $0.19 per share, and an increase next year of $0.03 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.
Greystone Housing Impact Investors LP Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |